Prevention of ovarian cancer by administration of a vitamin D compound
AssigneeNew Life Pharmaceuticals Inc.
InventorsGustavo C. Rodriguez, Regina Salas Whitaker
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.
Claims10
A method of inhibiting conversion of non-normal non-neoplastic ovarian epithelial cells to neoplastic cells comprising administering to a female subject in need thereof a Vitamin D compound sensitive to inhibiting such conversion, wherein said Vitamin D compound is administered in an amount effective to inhibit conversion of non-normal non-neoplastic ovarian epithelial cells to neoplastic cells.
Dependencies are inferred from the claim text.